Other published non-procedural treatments for SPG which were not used in our cohort include aspirin, epoprostenol, recombinant tissue plasminogen activator (rTPA), sympathetic blockade and thrombomodulin (19, 48). Here, PLAT is linked to hereditary spastic paraplegia.